Premalignant lesions and gastric cancer: Current understanding

被引：4
|
作者：
Athanasios Koulis [1 ,2 ]
ANDrew Buckle [1 ,2 ]
Alex Boussioutas [1 ,2 ,3 ]
机构：
[1] Upper Gastrointestinal Translational Laboratory, Peter Mac Callum Cancer Centre
[2] the Sir Peter Mac Callum Department of Surgical Oncology, the University of Melbourne
[3] Department of Medicine, Royal Melbourne Hospital, University of Melbourne
来源：
World Journal of Gastrointestinal Oncology | 2019年 / 11卷 / 09期
关键词：
Helicobacter pylori; Correa cascade; Atrophic gastritis; Intestinal metaplasia; Point of no return; Dysplasia; Stem cells; Gastric cancer;
D O I：
暂无
中图分类号：
R735.2 [胃肿瘤];
学科分类号：
100214 ;
摘要：
Over the last two decades there has been a broad paradigm shift in our understanding of gastric cancer(GC) and its premalignant states from gross histological models to increasingly precise molecular descriptions. In this review we reflect upon the historic approaches to describing premalignant lesions and GC, highlight the current molecular landscape and how this could inform future risk assessment prevention strategies.
引用
收藏
页码：665 / 678
页数：14
相关论文
共 50 条
  • [1] Premalignant lesions and gastric cancer: Current understanding
    Koulis, Athanasios
    Buckle, Andrew
    Boussioutas, Alex
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 11 (09) : 665 - 678
  • [2] Premalignant lesions in gastric cancer
    Yashima K.
    Sasaki S.
    Koda M.
    Kawaguchi K.
    Harada K.
    Murawaki Y.
    Clinical Journal of Gastroenterology, 2010, 3 (1) : 6 - 12
  • [3] Understanding the molecular landscape of gastric premalignant lesions
    Garai, Jone
    Piazuelo, Maria B.
    Camargo, Maria C.
    Correa, Pelayo
    Wilson, Keith
    Zabaleta, Jovanny
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (06)
  • [4] Immunotherapy for gastric premalignant lesions and cancer
    Zorzetto, Valerio
    Maddalo, Gemma
    Basso, Daniela
    Farinati, Fabio
    IMMUNOTHERAPY, 2012, 4 (06) : 587 - 599
  • [5] The progression of premalignant gastric lesions to gastric cancer in the Netherlands
    de Vries, A. C.
    van Grieken, N. C. T.
    Casparie, M. K.
    Meijer, G. A.
    Kuipers, E. J.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2007, 19 (10) : A66 - A66
  • [6] GASTRIC MICROBIOME INHIBITS THE DEVELOPMENT OF PREMALIGNANT LESIONS AND GASTRIC CANCER
    Kim, Jiseon
    Nam, Ki Taek
    Kim, Kwang H.
    Kim, Sung Hee
    Jeong, Haeng Dueng
    Lee, Yura
    Hur, Sumin
    Jeon, Donghun
    Uhm, Chanyang
    GASTROENTEROLOGY, 2023, 164 (06) : S468 - S468
  • [7] Biomarkers of Gastric Premalignant Lesions
    Garai, Jone
    Li, Li
    Zabaleta, Jovanny
    ADVANCING THE SCIENCE OF CANCER IN LATINOS, 2020, : 81 - 88
  • [8] THE GASTRIC MICROBIOME PLAYS A PROTECTIVE ROLE IN THE DEVELOPMENT OF PREMALIGNANT LESIONS AND GASTRIC CANCER
    Kim, Jiseon
    Jeong, Haeng Dueng
    Kim, Sung Hee
    Park, Donghwan
    Lee, Yura
    Uhm, Chanyang
    Nam, Ki Taek
    GASTROENTEROLOGY, 2024, 166 (05) : S983 - S983
  • [9] Endoscopic surveillance of premalignant gastric lesions
    Sebastian, S
    Seery, J
    O'Morain, C
    Buckley, M
    GUT, 2003, 52 (01) : 152 - 153
  • [10] The prevalence of premalignant gastric lesions in asymptomatic patients: Predicting the future incidence of gastric cancer
    den Hoed, C. M.
    van Eijck, B. C.
    Capelle, L. G.
    van Dekken, H.
    Biermann, K.
    Siersema, P. D.
    Kuipers, E. J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (08) : 1211 - 1218
12345